- Home
- Publications
- Publication Search
- Publication Details
Title
mTOR inhibitors as a new therapeutic option for epilepsy
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 13, Issue 6, Pages 627-638
Publisher
Informa UK Limited
Online
2013-06-06
DOI
10.1586/ern.13.49
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Original article Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis
- (2013) Harvey Sarnat et al. FOLIA NEUROPATHOLOGICA
- Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
- (2013) D. A. Krueger et al. NEUROLOGY
- Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis Complex
- (2013) Bo Zhang et al. PLoS One
- Detection of human papillomavirus in human focal cortical dysplasia type IIB
- (2012) Julie Chen et al. ANNALS OF NEUROLOGY
- Fetal Brain Lesions in Tuberous Sclerosis Complex: TORC1 Activation and Inflammation
- (2012) Avanita S. Prabowo et al. BRAIN PATHOLOGY
- Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling
- (2012) Sheng-jun Wang et al. BRAIN RESEARCH
- Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy
- (2012) Robin C. C. Ryther et al. Current Neurology and Neuroscience Reports
- Identification of new epilepsy treatments: Issues in preclinical methodology
- (2012) Aristea S. Galanopoulou et al. EPILEPSIA
- Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target
- (2012) Aristea S. Galanopoulou et al. EPILEPSIA
- Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation
- (2012) Erwin A. van Vliet et al. EPILEPSIA
- Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats
- (2012) Tamar Chachua et al. EPILEPSIA
- Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat
- (2012) Bo Zhang et al. EPILEPSIA
- The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex
- (2012) Sharon W. Way et al. HUMAN MOLECULAR GENETICS
- Multiple Roles for Mammalian Target of Rapamycin Signaling in Both Glutamatergic and GABAergic Synaptic Transmission
- (2012) M. C. Weston et al. JOURNAL OF NEUROSCIENCE
- Impaired Autophagy in Neurons after Disinhibition of Mammalian Target of Rapamycin and Its Contribution to Epileptogenesis
- (2012) J. McMahon et al. JOURNAL OF NEUROSCIENCE
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- The mTOR Signaling Pathway in the Brain: Focus on Epilepsy and Epileptogenesis
- (2012) Emilio Russo et al. MOLECULAR NEUROBIOLOGY
- De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
- (2012) Jeong Ho Lee et al. NATURE GENETICS
- mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy
- (2012) Emilio Russo et al. NEUROPHARMACOLOGY
- Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of Tuberous Sclerosis Complex
- (2012) Marco Cambiaghi et al. NEUROPHARMACOLOGY
- Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy
- (2012) Anna Sliwa et al. NEUROSCIENCE LETTERS
- The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway
- (2012) Delia M. Talos et al. PLoS One
- The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice
- (2012) Adam L. Hartman et al. PLoS One
- Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
- (2012) Atsushi Sato et al. Nature Communications
- Sustained Activation of mTOR Pathway in Embryonic Neural Stem Cells Leads to Development of Tuberous Sclerosis Complex-Associated Lesions
- (2011) Laura Magri et al. Cell Stem Cell
- Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice
- (2011) C. Nicole Sunnen et al. EPILEPSIA
- Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis
- (2011) Raffaella Cusmai et al. EPILEPSY & BEHAVIOR
- Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex
- (2011) Marta Perek-Polnik et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex
- (2011) S. Anderl et al. HUMAN MOLECULAR GENETICS
- Combination Therapy Targeting Akt and Mammalian Target of Rapamycin Improves Functional Outcome after Controlled Cortical Impact in Mice
- (2011) Juyeon Park et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features
- (2011) R. Pilarski et al. JOURNAL OF MEDICAL GENETICS
- Rapamycin Suppresses Mossy Fiber Sprouting But Not Seizure Frequency in a Mouse Model of Temporal Lobe Epilepsy
- (2011) P. S. Buckmaster et al. JOURNAL OF NEUROSCIENCE
- Rapamycin passes the torch: a new generation of mTOR inhibitors
- (2011) Don Benjamin et al. NATURE REVIEWS DRUG DISCOVERY
- A pulse rapamycin therapy for infantile spasms and associated cognitive decline
- (2011) Emmanuel Raffo et al. NEUROBIOLOGY OF DISEASE
- Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin
- (2011) Robert P. Carson et al. NEUROBIOLOGY OF DISEASE
- Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis
- (2011) Sharon S. McDaniel et al. NEUROSCIENCE LETTERS
- Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders
- (2011) Zhao Zhong Chong et al. Oxidative Medicine and Cellular Longevity
- Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex
- (2011) J. Goto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner
- (2011) S. Banerjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR: A pathogenic signaling pathway in developmental brain malformations
- (2011) Peter B. Crino TRENDS IN MOLECULAR MEDICINE
- Focal Cortical Dysplasias: clinical implication of neuropathological classification systems
- (2010) Roberto Spreafico et al. ACTA NEUROPATHOLOGICA
- Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia
- (2010) Silvia Carloni et al. Autophagy
- Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling
- (2010) Raman Sankar et al. EPILEPSIA
- STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice
- (2010) Ksenia A. Orlova et al. JOURNAL OF CLINICAL INVESTIGATION
- Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
- (2010) Xiaoxing Huang et al. NEUROBIOLOGY OF DISEASE
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders
- (2010) Dan Ehninger et al. TRENDS IN MOLECULAR MEDICINE
- Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation
- (2009) Cinzia Dello Russo et al. BIOCHEMICAL PHARMACOLOGY
- Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia
- (2009) M. C. Ljungberg et al. Disease Models & Mechanisms
- Focal cortical dysplasia: A genotype-phenotype analysis of polymorphisms and mutations in the TSC genes
- (2009) Christoph Gumbinger et al. EPILEPSIA
- Early control of seizures improves long-term outcome in children with tuberous sclerosis complex
- (2009) Roberta Bombardieri et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Rapamycin Reduces Seizure Frequency in Tuberous Sclerosis Complex
- (2009) Jennifer Muncy et al. JOURNAL OF CHILD NEUROLOGY
- Hamartin Variants That Are Frequent in Focal Dysplasias and Cortical Tubers Have Reduced Tuberin Binding and Aberrant Subcellular Distribution In Vitro
- (2009) Céline Lugnier et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Inhibition of the Mammalian Target of Rapamycin Signaling Pathway Suppresses Dentate Granule Cell Axon Sprouting in a Rodent Model of Temporal Lobe Epilepsy
- (2009) P. S. Buckmaster et al. JOURNAL OF NEUROSCIENCE
- The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy
- (2009) L.-H. Zeng et al. JOURNAL OF NEUROSCIENCE
- Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice
- (2009) J. Zhou et al. JOURNAL OF NEUROSCIENCE
- mTOR signaling: At the crossroads of plasticity, memory and disease
- (2009) Charles A. Hoeffer et al. TRENDS IN NEUROSCIENCES
- Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
- (2008) Ling-Hui Zeng et al. ANNALS OF NEUROLOGY
- Recent advances in neurobiology of Tuberous Sclerosis Complex
- (2008) Valerio Napolioni et al. BRAIN & DEVELOPMENT
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
- (2008) L. Meikle et al. JOURNAL OF NEUROSCIENCE
- Tuberous sclerosis
- (2008) Paolo Curatolo et al. LANCET
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Role of mTOR in physiology and pathology of the nervous system
- (2007) Lukasz Swiech et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started